An antisense oligonucleotide drug in development disrupts the synthesis of Apo(a) protein, leading to a complete obliteration of Lp(a) in phase two trials with no short-term side effects.

Every Sunday: the week’s new conflicts and verdict changes — and nothing else.

Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.